STUDY TO DETERMINE THE EFFICACY AND SAFETY OF STANDARD SCHEDULE VERSUS A NEW ALGORITHM OF DOSE REDUCTIONS IN ELDERLY AND UNFIT NEWLY DIAGNOSED MULTIPLE MYELOMA PATIENTS RECEIVING LENALIDOMIDE PLUS STEROIDS
Clinical trial NCT02215980 · COMPLETED
Trial details
- NCT number
- NCT02215980
- Sponsor
- Fondazione EMN Italy Onlus
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2014-07-01
- Primary completion
- 2022-07-01
- Enrollment
- 210
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.